Regional Anaesthesia Clinical Trials
2 recruiting trials for Regional Anaesthesia. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Regional Anaesthesia clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Jagiellonian University (1), University of Lisbon (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Celiac Plexus Block (drug, 1 trial), followed by ESP block, Lidacaine.
Track Regional Anaesthesia trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Comparison of the Efficacy of Celiac Plexus Blockade, ESP and Lidocaine Infusion Under OFA
Modern anesthesiology, in search of alternatives to opioid-based pain management, is turning to low-opioid and non-opioid protocols. Replacing opioids with non-opioid analgesics,...
Regional Versus General Anesthesia for Hip Fracture and Postoperative Oxygenation
With this study, the investigators intend to measure oxygen saturation before and after hip surgery in the context of proximal femur fracture, comparing two types of anesthesia...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Regional Anaesthesia, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Regional Anaesthesia, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Regional Anaesthesia, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.